Table 4.

Parameter estimates for full linear mixed-effects model

Characteristics	Coefficient	CI Lower Upper		P value
Intercept	19.03	18.11	19.95	0.000
Sex
Female	0.00
Male	−0.01	−0.51	0.48	0.956
Adherence
Poor	0.00
Fair	0.43	−0.24	1.10	0.207
Good	0.48	−0.06	1.02	0.080
INH prophylaxis given
No	0.00
Yes	0.87	0.32	1.42	0.002
CPT prophylaxis given
No	0.00
Yes	0.63	0.08	1.19	0.025
Educational status
Illiterate	0.00
Primary	−0.03	−0.72	0.66	0.924
Secondary	0.47	−0.21	1.14	0.176
Tertiary	0.94	−0.01	1.89	0.051
Functional status
Working	0.00
Ambulatory	−1.16	−1.95	−1.31	0.000
Bedridden	−1.83	−2.47	−1.21	0.000
WHO stage
Stage I	0.00
Stage II	−0.06	−0.45	0.33	0.760
Stage III	−0.42	−0.65	−0.20	0.000
Stage IV	−0.62	−1.02	−0.22	0.002
CD4 count	0.001	0.0008	0.0015	0.000
Time on treatment	0.013	0.004	0.022	0.005
Education status × time
Illiterate × time	0.00
Primary × time	0.002	−0.01	0.015	0.801
Secondary × time	0.01	−0.003	0.019	0.162
Tertiary × time	0.02	0.01	0.04	0.009
Functional status × time
Working × time	0.00
Ambulatory × time	0.03	0.01	0.05	0.000
Bedridden × time	−0.01	−0.05	0.02	0.49
WHO stage × time
Stage I × time	0.00
Stage II × time	0.004	−0.008	0.166	0.522
Stage III × time	0.01	0.007	0.020	0.000
Stage IV × time	−0.0003	−0.016	0.016	0.969

CPT, cotrimoxazole prophylaxis; INH, isoniazid.